Cardiovascular risk in diabetic end-stage renal disease patients.
about
The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic ReviewRenal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study.Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index.The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease.Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
P2860
Cardiovascular risk in diabetic end-stage renal disease patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk in diabetic end-stage renal disease patients.
@en
Cardiovascular risk in diabetic end-stage renal disease patients.
@nl
type
label
Cardiovascular risk in diabetic end-stage renal disease patients.
@en
Cardiovascular risk in diabetic end-stage renal disease patients.
@nl
prefLabel
Cardiovascular risk in diabetic end-stage renal disease patients.
@en
Cardiovascular risk in diabetic end-stage renal disease patients.
@nl
P2860
P1433
P1476
Cardiovascular risk in diabetic end-stage renal disease patients.
@en
P2093
Angela Yee-Moon Wang
P2860
P304
P356
10.1111/J.1753-0407.2011.00113.X
P577
2011-06-01T00:00:00Z